Local Anaesthesia Flashcards

1
Q

What precautions are required for safe analgesia?

A
  1. Thorough and concurrent medical history taking including LA history and experience, anxiety levels
  2. Good patient cooperation and consent
  3. Safe disposal/single use
  4. Needle guards/safety systems
  5. Sharps boxes
  6. Semi-recumbent position
  7. Self aspirating syringe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the constituents of Local Anaesthetics?

A
  1. Aromatic region (lipid soluble)
  2. Ester/amide bond (determines biotransformation)
  3. Basic amine side chain (water solubility)
    - Weak bases with a pKa rof 8-9 = mainly ionised at physiological pH (7.4) – important as it determines their ability to penetrate the nerve sheath and axon membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is presence of an ester or amide bond an important factor to consider when choosing an LA?

A
  1. Ester containing compounds are fairly rapidly inactivated in the plasma and liver by non-specific esterases
  2. Amides* are more stable and these analgesics generally have longer plasma half-lives
    - Low potential for producing allergic effects and the breakdown is more complex = slower = superior analgesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What’s the importance of having a lipophilic and water soluble groups?

A
  1. Lipophilic part of the compound helps the LA pass through neuron membrane
    - The fat soluble form of LA penetrates the lipid part of the neuron membrane
    - The strength of LA is directly related to its lipid solubility
  2. Once inside the lipophilic part is inside the cell and a new equilibrium with the water soluble part will be established and is responsible for the analgesic effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rank amide LA’s (H-L) by their lipid solubility

A
  1. Articaine
  2. Lidocaine
  3. Prilocaine
  4. Mepivacaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What’s the general mechanism of action for LA’s?

A
  • Block the initiation and propagation of action potentials by preventing the voltage-dependent increase in Na+ conductance
  • At low concentrations it decreases the rate of rise action potential - increasing its duration an increases the refractory period thus reducing firing rate
  • High concentrations they prevent action potential firing
  • Physically plug the transmembrane pore of Na+ channels - interacting with amino acid residues of the S6 transmembrane helical domain of the channel protein (at the nodes of ranvier)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where is the main site of action for LA’s?

A

Small-diameter nerve fibres

  • Block conduction in small-diameter nerve fibres more readily than large fibres
  • Nociceptive impulses are carried by Aδ and C fibres which are relatively small in diameter = pain sensation is blocked more readily than other sensory modalities (touch etc)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Before administering LA, why should you consider the pH of the environment you’re administering it into?

A
  • LA activity is strongly pH-dependent, being increased at alkaline extracellular pH (when proportion of ionised molecules is low)

In an alkaline environment** There is no electrical charge so they have lipophilic activity and adequate tissue penetration

  • Activity is reduced at acid pH
  • Extracellular fluid of inflamed tissue depends to be relatively acidic = somewhat resistant to LA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does LA cause in increase in perfusion of blood and what are the 2 resulting effects of this?

A

Increased perfusion due to Vasodilation effect
- Direct effect on vascular smooth muscle and partial inhibition of symapthetic nervous system = fall in blood pressure

  1. Drug is carried away from the site of admission = less effective
  2. Suppression of cardiovascular system
    - Absorption into systemic circulation causes myocardial depression, conduction block and vasodilation
  • Reduction in myocardial contractility via indirect inhibition of Na+ current in cardiac muscle – reduces intracellular Ca2+ stores = reduces force of contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can LA effect the CNS?

A

Both depressant and stimulant

  • Depressant at lower levels
  • High levels cause restlessness/tremors/confusion/extreme agitation
  • Profoundly high concentrations cause severe CNS depression and death due to respiratory depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can do we counter the vasodilation effect of LA?

A

Addition of a vasoconstrictor (epinephrine/adrenaline)

  • Maintains effective concentrations of LA at the site of injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What’s the significance of protein binding in relation to LA’s duration time?

A
  • LA in solution binds to both plasma and tissue proteins
  • Protein binding effects duration time = higher the binding to plasma proteins the longer it will be active (isn’t free to be metabolised)
  1. Articaine = >90% plasma binding
  2. Lidocaine = 60%
  3. Prilocaine = 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What factors determine onset and duration of LA?

A
  1. Alkaline tissue = higher the alkaline the tissue pH the quicker the onset (ability to diffuse across the phospholipid bilayer increases)
  2. Total dose = volume determines spread - high dose = high spread
  3. Concentration = strength of effect = higher the concentration the stronger the effect
  4. Duration = diffusion form the site of administration followed by redistribution in the tissue - low diffusion = increased duration
  5. Total dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What’s the primary factor determining local elimination of LA?

A

The degree of vascularisation of the tissue - determines the amount and velocity of loss

  • Additionally, LA’s vasodilation effect influences the rate of local elimination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacokinetics: how are amide-linked drugs eliminated from circulation?

A
  • Primarily metabolised in the liver (70-90%) via N-dealkylation rather than cleavage of amide group
  • Excreted by the kidney (10-30% unchanged)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Your patient has liver disease/impaired function, what should you consider when administering LA?

A
  • They degrade amide-type LA’s at a delayed rate which increases the risk of toxicity in these patients (toxic in the sense that it still exhibits LA characteristics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Lidocaine and what are its properties?

A
  • Gold standard LA

Onset = Rapid (2-3 min)

Duration = Medium (1-1.5hrs pulpal + 3-4hr tissue)

Tissue penetration = good

MRD = 7mg/kg of body weight (500mg max)

  • Combined with Epinephrine to increase pulpal anaesthesia (1:80,000 conc)
  • Dissoolved in solution as hydrochloride salt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Prilocaine and what are its properties?

A

Onset = Medium

Duration = Medium

Tissue penetration = moderate

  • Large doses - methemoglobinemia - reduces 02 carry capacity of the blood
  • More rapidly metabolised than Lidocaine = less toxic
  • Can be found in the form of EMLA cream - topical analgesic cream to numb an area before injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Articane and what are its properties?

A

Onset = Rapid

Duration = Short

Tissue penetration = Good

  • Hybrid amide with ester properties
  • Rapidly metabolised (quickest) - advantageous in relation to toxicity when repeated injections are necessary during a long procedure (someone with liver problems)
  • Ability to readily diffuse through structures - buccal infiltrations giving palatal anaesthesia diffuse through dense mandibular bone to affect Inferior dental nerve when infiltration given buccally (x4 more diffusible than lidocaine)
  • Typically used in oral surgery or long operative times where repeat injections are necessary
20
Q

How drastic are the changes to onset and duration of anaesthesia when epinephrine is added to Lidocaine?

A

2% lidocaine sol for infiltration without epinephrine:

Onset: <2 mins
Pulpal an: 5-10 min
Soft tissue: 1-2 hrs

Addition of 1:80,000 epinephrine:

Pulpal an: 60-90 min
Soft tissue: 3-3.5 hrs

21
Q

What are the benefits of Epinephrine as a vasoconstrictor?

A
  • More profound analgesia
  • Longer lasting pulpal anaesthesia
  • Control of haemorrhage
22
Q

What are the drawbacks of Epinephrine as a vasoconstrictor?

A
  • Can elevate systolic blood pressure by up to 70mgHg
  • Can increase HR by 25-70bpm

CRUCIAL TO ADMINISTER SLOWLY

23
Q

Why is age an important factor when considering LA dosage?

A

Liver function decreases with time therefore the maximum dosage decreases

24
Q

Before administering LA, it is important to make sure the medical history covers which areas?

A
  1. Cardiovascular disease - LA’s CNS inhibition effect
  2. BP disorders - LA’s ability to decrease BP
  3. Asthma - LA’s pulmonary depression
  4. Diabetes - Epinephrine is an antagonist to Insulin so can increase blood glucose levels - look at lowering the conc of epinephrine used
  5. Epilepsy/convulsions - inadvertent administration intravenously can cause convulsion
  6. Recreational drugs - epinephrine potentiating effects of cocaine etc
  7. Bleed easily - vasodilator effect of LA without vasoconstrictor can cause profuse bleeding
  8. Previous LA experiences
25
Q

What are the potential complication of local analgesics?

A
  1. Physical trauma: patient can injure themselves by chewing/biting/burning themselves afterwards - won’t feel it
    - Can cause Oedema
  2. Toxicity+Intravascular injection: Administering full cartridge of adrenaline containing LA won’t increase adrenaline levels to that when its naturally produced by the body under stressful conditions
26
Q

Which components of LA can cause an allergy?

A

All

  • When patients report symptoms of rashes or difficulty in breathing with previous injections, ask:
    + Describe reaction
    + How was it managed
  1. Allergy to amide LA’s are almost nill
  2. Allergy to adrenaline are more likely endogenous release to the injection
  3. Allergy to Potassium Metabisulphate may rarely cause severe allergic reactions and difficulty in breathing
  4. Allergy to latex should be considered as some cartridge plungers contain latex – can produce anaphylaxis in patients
27
Q

If a patient suffers from liver disease or alcohol abuse, if there a risk associated with using LA?

A

High risk of toxicity due to impaired metabolism - liver is main site of metabolism for amides - use LA with caution or those which can be metabolised quickly

28
Q

If your patient is pregnant, are there any potential risks if administering LA?

A
  • Felypressin (adrenaline alternative) has an oxytocic effect on the uterus BUT the dose to induce labour = 100 dental cartridges
  • LA agents can diffuse across the placenta
    1. PRILOCAINE diffuses most = SHOULDN’T BE USED
  • Try not to treat pregnant patients in their 1st and last trimesters
29
Q

What are the contraindications to using LA?

A
  • Remember that fear and anxiety can reduce pain threshold so patients can interpret non-painful stimuli like pressure or cold air as pain

Not suitable for:

  1. Very old
  2. Very young
  3. Severely mentally handicapped
  4. Unreasonable patient
30
Q

What are the systemic contraindications to administering LA?

A

Patients with:

  1. Leukaemia
  2. Anticoagulant therapy
  3. Liver dysfunction - metabolism
  4. Renal disease - excretion
  5. Local sepsis/vascular abnormalities/periostatic tooth
  6. Pregnancy (timing and management)
  7. Uncontrolled diabetes
  8. Septicaemia
  9. Haemophilia - blood doesn’t clot - avoid deep regional block anaesthesia unless prophylaxis has been employed
31
Q

What are the local complications to administering LA?

A
  1. Failure to anaesthetise - stop trying
  2. Infection - local tissue pH change - reduction in LA efficiency
  3. Intra-vascular injection
  4. Haematoma
  5. Nerve damage
  6. Needle fracture
  7. Cartridge failure
  8. Facial palsy
  9. Needle stick injury - either self or patient; stop procedure
32
Q

The tooth which needs LA has an infection and abscess; what do you do?

A
  • Sort infection/abscess before administering LA
  • All injections into an infected area should be avoided as it can spread/exacerbate the infection
  • Acidosis in the local tissue causes lower pH of the tissue = less potent effect of LA
  • Inject medially or distally to the tooth to be operated on or administer a regional block instead of infiltration
33
Q

If you administer LA too quickly or too much, what are the potential consequences?

A
  • Can cause tearing and postoperative pain
  • Need to administer LA slowly and a small amount just enough to give blanching
  • Tissue necrosis can be seen on the hard palate if inject with too much pressure - Vasoconstictor induces the narrowing of the palatine end arteries which results in neocrotic ulcers of the mucosa – HEALS
34
Q

You administer LA but puncture a vein, what’s the potential repercussion?

A

Haematoma

  • Immediate swelling as blood leaks into tissues
  • Reduces within days
  • Try and avoid injections directly where there are visible vessels or anatomical landmarks - plexus areas – remember to aspirate
35
Q

You administer LA and lacerate a nerve, what will the patient experience and what should you do?

A
  • Laceration can happen during regional blocks if needle penetrates nerve sheath
  • Patient reports an electric shock feeling
  • If parathesiae is elicited the needle should be withdrawn a little - if not then risk of damage is greater
  • Injections into restricted spaces, canals, and foramina are especially dangerous
36
Q

You’ve accidentally administered a IDB deep into the parotid sheath; what is the possible consequence of this?

A
  • Solution introduced to the parotid gland - can then causes paralysis of the facial nerve = hemi facial paresis
  • Paralysis will resolve as the LA wears off but eye protection must be given
  • Rapid injection of a large amount of LA into the maxillary sulcus can effect some fibres of facial nerve - eyelids cannot close so eye protection is needed until motor control is restored
37
Q

You accidentally cause bleeding when administering an intramuscular injection in the medial pyerygoid muscle; what can this occur?

A
  • Trismus (jawlock)

- Symptoms may appear 1 or 2 days post operatively and may persist for a period of time

38
Q

You’ve finished your treatment, what should you instruct your patient to do?

A
  1. Warn them of the expected duration of the anaesthetic
  2. Care with hot liquids (easily burn themselves without knowing)
  3. Do not scratch or chew the area
  4. Altered sensation when anaesthesia is wearing off - tingling/ pins and needles
    - Instructions must be given and documented in the notes
39
Q

Maxillary distribution of nerve supply: What nerve supplies the Palatal gingivae, teeth and buccal gingivae for the central/lateral incisors and canine?

A
  1. Nasopalatine nerve
  2. Anterior superior alveolar nerve
  3. Infraorbital nerve
40
Q

Maxillary distribution of nerve supply: What nerve supplies the Palatal gingivae, teeth and buccal gingivae for the 1st premolar, 2nd premolar and 1st molar?

A
  1. Greater palatine nerve
  2. Middle superior alveolar nerve
  3. Posterior superior alveolar nerve and buccal nerve
41
Q

Maxillary distribution of nerve supply: What nerve supplies the Palatal gingivae, teeth and buccal gingivae for the 2nd and 3rd molar?

A
  1. Greater palatine nerve
  2. Posterior superior alveolar nerve
  3. Posterior superior alveolar nerve and buccal nerve
42
Q

Mandibular distribution of nerve supply: What nerve supplies the Buccal gingivae, teeth and Lingual gingivae for the central/lateral incisors, canine and 1st premolar? (block both sides)

A
  1. Mental nerve
  2. Incisive nerve
  3. Lingual nerve and perforating branches of inferior alveolar nerve
43
Q

Mandibular distribution of nerve supply: What nerve supplies the Buccal gingivae, teeth and Lingual gingivae for the 2nd premolar, 1st molar, 2nd molar and 3rd molar?

A
  1. Buccal nerve and perforating branches of inferior nerve
  2. Inferior alveolar nerve
  3. Lingual nerve and perforating branches of inferior alveolar nerve
44
Q

Why shouldn’t you use Articaine for IDB?

A

Articaine has been associated with higher risk of nerve damage so use Lidocaine

45
Q

If you’re administering an IDB and you see the patients cheek blanching, what does this indicate?

A
  • You have injected LA into a blood vessel (maxillary artery) - warn patient that it will go back to normal once the local has warn off